JT
ZBIO

Jupiter Topco’s Zenas BioPharma ZBIO Stock Holding History

Jupiter Topco’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Buy
+7,900
New +$157K ﹤0.01% 2404

Other funds holding ZBIO

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jupiter Topco's ZBIO Position: Q2 2026 in Review

Jupiter Topco opened a new position in Zenas BioPharma (ZBIO) in Q2 2026: 7,900 shares worth $201K. The stake represents ﹤0.01% of the portfolio and ranks #2404 among its holdings.

132 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • Jupiter Topco held 7,900 shares of Zenas BioPharma worth $201K as of Q2 2026.
  • Zenas BioPharma was a new Jupiter Topco position in Q2 2026.
  • Zenas BioPharma made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #2404 holding.
  • 132 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.